187 related articles for article (PubMed ID: 30631425)
1. Understanding overactive bladder and urgency incontinence: what does the brain have to do with it?
Smith AL
F1000Res; 2018; 7():. PubMed ID: 30631425
[TBL] [Abstract][Full Text] [Related]
2. Abnormal functional connectivity in women with urgency urinary incontinence: Can we predict disease presence and severity in individual women using Rs-fcMRI/.
Nardos R; Karstens L; Carpenter S; Aykes K; Krisky C; Stevens C; Gregory WT; Fair DA
Neurourol Urodyn; 2016 Jun; 35(5):564-73. PubMed ID: 25933352
[TBL] [Abstract][Full Text] [Related]
3. Specific Changes in Brain Activity during Urgency in Women with Overactive Bladder after Successful Sacral Neuromodulation: A Functional Magnetic Resonance Imaging Study.
Weissbart SJ; Bhavsar R; Rao H; Wein AJ; Detre JA; Arya LA; Smith AL
J Urol; 2018 Aug; 200(2):382-388. PubMed ID: 29630979
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Changes in Cerebral Perfusion during Urinary Urgency in Women with Overactive Bladder.
Arya NG; Weissbart SJ; Xu S; Bhavsar R; Rao H
Biomed Res Int; 2017; 2017():2759035. PubMed ID: 28904950
[TBL] [Abstract][Full Text] [Related]
5. Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle.
Dokmeci F; Cetinkaya SE; Seval MM; Dai O
Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():126-131. PubMed ID: 28355584
[TBL] [Abstract][Full Text] [Related]
6. Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial.
Chapple C; Schneider T; Haab F; Sun F; Whelan L; Scholfield D; Dragon E; Mangan E
BJU Int; 2014 Sep; 114(3):418-26. PubMed ID: 24552358
[TBL] [Abstract][Full Text] [Related]
7. Urgency urinary incontinence and the interoceptive network: a functional magnetic resonance imaging study.
Ketai LH; Komesu YM; Dodd AB; Rogers RG; Ling JM; Mayer AR
Am J Obstet Gynecol; 2016 Oct; 215(4):449.e1-449.e17. PubMed ID: 27173081
[TBL] [Abstract][Full Text] [Related]
8. Bladder control, urgency, and urge incontinence: evidence from functional brain imaging.
Griffiths D; Tadic SD
Neurourol Urodyn; 2008; 27(6):466-74. PubMed ID: 18092336
[TBL] [Abstract][Full Text] [Related]
9. Mind-body (hypnotherapy) treatment of women with urgency urinary incontinence: changes in brain attentional networks.
Ketai LH; Komesu YM; Schrader RM; Rogers RG; Sapien RE; Dodd AB; Mayer AR
Am J Obstet Gynecol; 2021 May; 224(5):498.e1-498.e10. PubMed ID: 33122028
[TBL] [Abstract][Full Text] [Related]
10. Urgency assessment in the evaluation of overactive bladder (OAB).
Starkman JS; Dmochowski RR
Neurourol Urodyn; 2008; 27(1):13-21. PubMed ID: 17671973
[TBL] [Abstract][Full Text] [Related]
11. Functional connectivity of the brain in older women with urgency urinary incontinence.
Clarkson BD; Karim HT; Griffiths DJ; Resnick NM
Neurourol Urodyn; 2018 Nov; 37(8):2763-2775. PubMed ID: 30054930
[TBL] [Abstract][Full Text] [Related]
12. Brain activity underlying impaired continence control in older women with overactive bladder.
Tadic SD; Griffiths D; Schaefer W; Murrin A; Clarkson B; Resnick NM
Neurourol Urodyn; 2012 Jun; 31(5):652-8. PubMed ID: 22473921
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials.
DuBeau CE; Morrow JD; Kraus SR; Creanga D; Bavendam T
Neurourol Urodyn; 2012 Nov; 31(8):1258-65. PubMed ID: 22907761
[TBL] [Abstract][Full Text] [Related]
14. Urgency severity scale could predict urodynamic detrusor overactivity in patients with overactive bladder syndrome.
Chung SD; Liao CH; Chen YC; Kuo HC
Neurourol Urodyn; 2011 Sep; 30(7):1300-4. PubMed ID: 21560153
[TBL] [Abstract][Full Text] [Related]
15. Chapter 1: The conditions of neurogenic detrusor overactivity and overactive bladder.
Haab F
Neurourol Urodyn; 2014 Jul; 33 Suppl 3():S2-5. PubMed ID: 25042138
[TBL] [Abstract][Full Text] [Related]
16. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
[TBL] [Abstract][Full Text] [Related]
17. Mirabegron for overactive bladder syndrome.
Drug Ther Bull; 2013 Aug; 51(8):90-2. PubMed ID: 23949821
[TBL] [Abstract][Full Text] [Related]
18. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
[TBL] [Abstract][Full Text] [Related]
19. Cerebral control of the bladder in normal and urge-incontinent women.
Griffiths D; Tadic SD; Schaefer W; Resnick NM
Neuroimage; 2007 Aug; 37(1):1-7. PubMed ID: 17574871
[TBL] [Abstract][Full Text] [Related]
20. Overactive bladder symptoms after midurethral sling surgery in women: Risk factors and management.
Marcelissen T; Van Kerrebroeck P
Neurourol Urodyn; 2018 Jan; 37(1):83-88. PubMed ID: 28631830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
